Elevance raises outlook ahead of consensus after strong YTD performance (NYSE:ELV)
seekingalpha.com
finance
2022-10-19 10:56:00

mohd izzuan Elevance Health (NYSE:ELV), the managed care organization formerly known as Anthem, traded higher in the pre-market Wednesday after the company beat expectations with its Q3 2022 financials and raised the full-year guidance ahead of consensus citing robust YTD performance. The operating revenue for the period exceeded the consensus adding $39.6B with ~12% YoY growth thanks to higher premium revenue due to Medicaid membership growth. As of Sep. 30, ELV reported ~47.3M of medical membership, up 2.
